Back to Search Start Over

Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.

Authors :
Al Dali S
Al-Badriyeh D
Gulied A
Hamad A
Hail MA
Rouf PVA
El-Kassem W
Abushanab D
Source :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 792-801. Date of Electronic Publication: 2023 Jul 11.
Publication Year :
2024

Abstract

Introduction: Drug-related problems (DRPs) affect the health outcomes of patients during hospitalization. We sought to analyze the clinical pharmacist-documented interventions among hospitalized patients in the cancer hospital in Qatar.<br />Methods: A retrospective analysis of electronically reported clinical pharmacist interventions of patients admitted to cancer units at Hamad Medical Corporation, Qatar was conducted. Extracted data was based on an overall 3-month follow-up period; March 1-31, 2018, July 15-August 15, 2018 and January 1-31, 2019. Categorical variables were expressed as frequencies and percentages, while continuous variables were expressed as mean ± standard deviation (SD).<br />Results: A total of 281 cancer patients with 1354 interventions were included. The average age of the study participants was 47 years (SD ± 17.36). The majority of the study population was females ( n  = 154, 54.80%). The prevailing pharmacist intervention was the addition of a drug therapy ( n  = 305, 22.53%), followed by medication discontinuation ( n  = 288, 21.27%) and the addition of a prophylactic agent ( n  = 174, 12.85%). This pattern was similar across all subgroups (i.e., gender, age, ward), except for the urgent care unit, where an increase in medication dose was the third highest frequently identified intervention ( n  = 3, 0.22%). The two medication groups associated with the majority of interventions were the anti-infective and fluid/electrolyte agents. Most of the interventions documented were in the oncology ward (73.19%), while the urgent care unit had the least documented interventions (1.62%).<br />Conclusions: Our analysis showed that clinical pharmacists can effectively identify and prevent DRPs among hospitalized cancer patients.<br />Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Details

Language :
English
ISSN :
1477-092X
Volume :
30
Issue :
5
Database :
MEDLINE
Journal :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Publication Type :
Academic Journal
Accession number :
37431260
Full Text :
https://doi.org/10.1177/10781552231187305